Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives,” published in the ...

New analysis shows promising repigmentation with JAK inhibitors in vitiligo, especially in combination with UVB. Safety and ...

In a meta-analysis, topical Janus kinase (JAK) inhibitors demonstrated promising but non-significant results for vitiligo ... with those using a vehicle cream. However, single-arm trials and ...

Autoimmune pathology characterised by skin depigmentation, vitiligo is subject to many clichés. This dermatological disease is not psychosomatic, but the consequences it has on patients' lives cause a ...

She said for individuals with mild vitiligo, non-steroidal creams like tacrolimus, pimecrolimus and calcipotriol can be applied to the affected areas. "Those with more severe vitiligo may be ...

Results in vitiligo came from the TRuE-V1 and TRuE-V2 studies, which showed that around 30% of patients treated with ruxolitinib cream twice daily achieved 75% or more improvement from baseline in ...

Harlow partnered with eBay to curate an exclusive auction of pre-loved luxury fashion for Miami’s F1 race weekend, where she ...

The FDA has approved Incyte's Opzelura cream for atopic dermatitis ... indication as a treatment for skin pigmentation disease vitiligo. Its approval for atopic dermatitis was delayed by three ...

These creams cause blood cells to dilate ... topical steroid to relieve inflammation and itching if necessary. Vitiligo is an autoimmune condition that causes areas of the skin to lose pigmentation.

Phototherapy with topical antioxidants is the most effective combination for vitiligo, followed by corticosteroids and calcineurin inhibitors.